These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9765932)

  • 1. Mechanistic probes of flavocytochrome P-450 BM3.
    Noble MA; Turner KL; Chapman SK; Munro AW
    Biochem Soc Trans; 1998 Aug; 26(3):S213. PubMed ID: 9765932
    [No Abstract]   [Full Text] [Related]  

  • 2. Redox characterisation of flavocytochrome P-450 BM3 from Bacillus megaterium.
    Munro AW; Daff SN; Turner KL; Chapman SK
    Biochem Soc Trans; 1997 Nov; 25(4):S628. PubMed ID: 9450056
    [No Abstract]   [Full Text] [Related]  

  • 3. The interaction of eukaryotic cytochrome b5 with flavocytochrome P-450 BM3 from Bacillus megaterium.
    Munro AW; Noble MA; Turner KL; Chapman SK
    Biochem Soc Trans; 1998 Aug; 26(3):S212. PubMed ID: 9765931
    [No Abstract]   [Full Text] [Related]  

  • 4. Formation of flavin semiquinone during the reduction of P450 BM3 reductase domain with NADPH.
    Munro AW; Coggins JR; Lindsay JG; Daff S; Chapman SK
    Biochem Soc Trans; 1996 Feb; 24(1):18S. PubMed ID: 8674656
    [No Abstract]   [Full Text] [Related]  

  • 5. Probing inter-domain electron transfer in a model flavocytochrome P-450.
    Munro AW; Daff SN; Turner KL; Chapman SK
    Biochem Soc Trans; 1997 Nov; 25(4):S629. PubMed ID: 9450057
    [No Abstract]   [Full Text] [Related]  

  • 6. Deflavination of cytochrome P450 BM3 by treatment with guanidinium chloride.
    Munro AW; Coggins JR; Lindsay JG; Kelly S; Price NC
    Biochem Soc Trans; 1996 Feb; 24(1):19S. PubMed ID: 8674659
    [No Abstract]   [Full Text] [Related]  

  • 7. Imidazolyl carboxylic acids as mechanistic probes of flavocytochrome P-450 BM3.
    Noble MA; Quaroni L; Chumanov GD; Turner KL; Chapman SK; Hanzlik RP; Munro AW
    Biochemistry; 1998 Nov; 37(45):15799-807. PubMed ID: 9843385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional saturation mutagenesis as an approach to identification of substrate specificity determinants in cytochrome P450 BM3.
    Munro AW; Coggins JR; Lindsay JG
    Biochem Soc Trans; 1993 Nov; 21(4):409S. PubMed ID: 8131983
    [No Abstract]   [Full Text] [Related]  

  • 9. Expression, purification, and characterization of Bacillus subtilis cytochromes P450 CYP102A2 and CYP102A3: flavocytochrome homologues of P450 BM3 from Bacillus megaterium.
    Gustafsson MC; Roitel O; Marshall KR; Noble MA; Chapman SK; Pessegueiro A; Fulco AJ; Cheesman MR; von Wachenfeldt C; Munro AW
    Biochemistry; 2004 May; 43(18):5474-87. PubMed ID: 15122913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The catalytic mechanism of cytochrome P450 BM3 involves a 6 A movement of the bound substrate on reduction.
    Modi S; Sutcliffe MJ; Primrose WU; Lian LY; Roberts GC
    Nat Struct Biol; 1996 May; 3(5):414-7. PubMed ID: 8612070
    [No Abstract]   [Full Text] [Related]  

  • 11. Alkane metabolism by cytochrome P450 BM3.
    Munro AW; Lindsay JG; Coggins JR
    Biochem Soc Trans; 1993 Nov; 21(4):412S. PubMed ID: 8131986
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of flavin reoxidation in P450 BM3 by diphenyliodonium chloride.
    Munro AW; Coggins JR; Lindsay JG
    Biochem Soc Trans; 1996 Feb; 24(1):17S. PubMed ID: 8674653
    [No Abstract]   [Full Text] [Related]  

  • 13. Probing electron transfer in flavocytochrome P-450 BM3 and its component domains.
    Munro AW; Daff S; Coggins JR; Lindsay JG; Chapman SK
    Eur J Biochem; 1996 Jul; 239(2):403-9. PubMed ID: 8706747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the interactions of cytochrome b5 with flavocytochrome P450 BM3 and its domains.
    Noble MA; Girvan HM; Smith SJ; Smith WE; Murataliev M; Guzov VM; Feyereisen R; Munro AW
    Drug Metab Rev; 2007; 39(2-3):599-617. PubMed ID: 17786641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resonance Raman spectroscopic studies on intact cytochrome P450 BM3.
    Munro AW; Lindsay JG; Coggins JR; MacDonald I; Smith WE; Rospendowski BN
    Biochem Soc Trans; 1994 Feb; 22(1):54S. PubMed ID: 8206282
    [No Abstract]   [Full Text] [Related]  

  • 16. Flavocytochrome P450 BM3: an update on structure and mechanism of a biotechnologically important enzyme.
    Warman AJ; Roitel O; Neeli R; Girvan HM; Seward HE; Murray SA; McLean KJ; Joyce MG; Toogood H; Holt RA; Leys D; Scrutton NS; Munro AW
    Biochem Soc Trans; 2005 Aug; 33(Pt 4):747-53. PubMed ID: 16042591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The bacterial P450 BM3: a prototype for a biocatalyst with human P450 activities.
    Yun CH; Kim KH; Kim DH; Jung HC; Pan JG
    Trends Biotechnol; 2007 Jul; 25(7):289-98. PubMed ID: 17532492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineering the substrate specificity of Bacillus megaterium cytochrome P-450 BM3: hydroxylation of alkyl trimethylammonium compounds.
    Oliver CF; Modi S; Primrose WU; Lian LY; Roberts GC
    Biochem J; 1997 Oct; 327 ( Pt 2)(Pt 2):537-44. PubMed ID: 9359427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Redox control of the catalytic cycle of flavocytochrome P-450 BM3.
    Daff SN; Chapman SK; Turner KL; Holt RA; Govindaraj S; Poulos TL; Munro AW
    Biochemistry; 1997 Nov; 36(45):13816-23. PubMed ID: 9374858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are branched chain fatty acids the natural substrates for P450(BM3)?
    Cryle MJ; Espinoza RD; Smith SJ; Matovic NJ; De Voss JJ
    Chem Commun (Camb); 2006 Jun; (22):2353-5. PubMed ID: 16733577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.